cGxP.wire https://validator.w3.org/feed/docs/rss2.html Castle Biosciences Shows TissueCypher Improves Barrett’s Care Galderma Advances Restylane Volyme in Chinese Temple Hollowing Chemify Raises £22M to Scale AI-Driven Chemistry Circle Pharma Raises $92.5M to Advance CID-165 Twist Bioscience Joins Lilly TuneLab for Antibody Discovery Adagio Medical Advances vCLAS Ultra in Ventricular Tachycardia Gilead Accelerates Global Access Planning for Once-Yearly Lenacapavir Mission Bio Launches Tapestri Triomics for Single-Cell Analysis AbCellera Presents Phase 2 Data for ABCL635 Longeveron Reports ELPIS II Results for Laromestrocel MAIA Biotechnology Doses First U.S. Patient in THIO-101 Kestrel Therapeutics Gains FDA Fast Track for KST-6051 Cogent Biosciences Gains FDA Acceptance for Bezuclastinibm ReEmerge Raises $37M to Advance Brain Injury Technology Vertex Partners With Lindsey Vonn to Highlight JOURNAVX Arrowhead Advances ARO-DIMER-PA in Mixed Hyperlipidemia Jubilant Therapeutics Reports JBI-802 MPN Clinical Data Skyhawk Therapeutics Reports 15-Month SKY-0515 Results HDT Bio Leads ARPA-H Program for Personalized RNA Thryv Therapeutics Advances THRV-1268 for Heart Failure Care Aptar Pharma and MGH Advance Nose-to-Brain Drug Delivery Mighty Therapeutics Develops POLG Disease Model for Research Ractigen Therapeutics Reports First-In-Human RNA Activation Data Lumicell Expands LumiSystem Use in Breast Cancer Surgery Now Applied Photonix Launches FDA-Cleared ViroZap Air Device Nitinotes Begins EASE Clinical Trial Procedures in Italy Mayo Clinic, Thermo Fisher Launch Precure for Early Signs AI QurCan Therapeutics and Lilly Advance Nucleic Acid Therapies Xylo Bio Advances XYL-1001 Phase 1 Trial in Major Depression Nanobiotix Advances JNJ-1900 in Recurrent NSCLC Pulse Biosciences Completes PRECISE-BTN Enrollment Syntis Bio Advances Oral SYNT-101 Toward Phase 2 Rocket Pharmaceuticals Advances RP-A501 Toward Danon Disease Approval One04 Therapeutics Launches With CPV-104 Clinical Expansion ENA Respiratory Advances INNA-051 Into Part B Phase IIa Acurx Pharmaceuticals Presents Ibezapolstat C. difficile Data Ocular Therapeutix Advances AXPAXLI Toward Wet AMD NDA Allergan Aesthetics Advances Skin Longevity Science Research Compass Pathways Launches Change the Tune in TRD Elanco Advances Pet Health Innovation as Tick Season Expands Summit Therapeutics Reports Ivonescimab Survival Data at WCLC Connect Biopharma Advances Rademikibart Toward Phase 3 PolarityBio Gains FDA Priority Review for SkinTE in DFUs Novo Nordisk Launches Novo Rebrand and New Corporate Culture Telix Gains FDA Approval for Pixclara in Glioma Imaging Pharmazz Gains FDA Orphan Designation for Sovateltide in NHIE Corbus Advances CRB-913 Toward Phase 2 in Obesity Debut Develops Biotech Ingredient for Hyperpigmentation Care Nuvation Bio Reports Durable IBTROZI Efficacy in ROS1+ NSCLC Waters Launches BD FACSDiscover A7 Spectral Flow Cytometer